Comparative Study
N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture
- PMID: 4371054
Item in Clipboard
Comparative Study
N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture
J Biol Chem.
.
Free article
No abstract available
Similar articles
-
Inhibition by N-(phosphonacetyl)-L-aspartate of aspartate transcarbamylase activity and drug-induced cell proliferation in mice.J Biol Chem. 1974 Nov 10;249(21):6951-5. J Biol Chem. 1974. PMID: 4418148 No abstract available.
-
Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.Cancer Res. 1983 May;43(5):2277-82. Cancer Res. 1983. PMID: 6831451
-
Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA).Cancer Treat Rep. 1979 Jan;63(1):85-8. Cancer Treat Rep. 1979. PMID: 421235
-
m-AMSA and PALA: two new agents in cancer chemotherapy.Cancer Chemother Pharmacol. 1979;3(3):135-41. doi: 10.1007/BF00262414. Cancer Chemother Pharmacol. 1979. PMID: 393427 Review.
-
Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review.Cancer Res. 1988 Aug 15;48(16):4441-54. Cancer Res. 1988. PMID: 3293772 Review. No abstract available.
Cited by
-
Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase.Front Cell Infect Microbiol. 2022 Mar 4;12:841833. doi: 10.3389/fcimb.2022.841833. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35310840 Free PMC article. Review.
-
Expression, purification, crystallization and preliminary X-ray diffraction analysis of the aspartate transcarbamoylase domain of human CAD.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1425-30. doi: 10.1107/S1744309113031114. Epub 2013 Nov 29. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013. PMID: 24316846 Free PMC article.
-
Genetic instability as a consequence of inappropriate entry into and progression through S-phase.Cancer Metastasis Rev. 1995 Mar;14(1):59-73. doi: 10.1007/BF00690212. Cancer Metastasis Rev. 1995. PMID: 7606822 Review.
-
Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.Cancer Chemother Pharmacol. 1992;29(4):305-8. doi: 10.1007/BF00685949. Cancer Chemother Pharmacol. 1992. PMID: 1537077 Clinical Trial.
-
TNFα-induced metabolic reprogramming drives an intrinsic anti-viral state.PLoS Pathog. 2022 Jul 14;18(7):e1010722. doi: 10.1371/journal.ppat.1010722. eCollection 2022 Jul. PLoS Pathog. 2022. PMID: 35834576 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
